Advanced Search

 

Study ID Status Title Patient Level Data
29060/664 Completed A single dose randomised three-period cross-over study to evaluate the effect of food on the bioavailability of a new 40 mg paroxetine tablet when administered in the fed and fasted state relative to the bioavailability of the standard 40 mg Paxil™ tablet administered in the fed state.
29060/665 Completed A Phase I Pharmacokinetic and Pharmacodynamic Study on the Potential Drug-Drug Interactions between Paroxetine and Alprazolam
29060/676 Completed A 16 Week Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Tolerability of Paroxetine in the Treatment of Children and Adolescents with Social Anxiety Disorder/Social Phobia. Study Listed on ClinicalStudyDataRequest.com
29060/677 Completed A Double-Blind, Placebo-Controlled, Three-Arm Fixed-Dose Study of Paroxetine CR Continuous Treatment (12.5 mg/day and 25 mg/day) for Premenstrual Dysphoric Disorder Study Listed on ClinicalStudyDataRequest.com
29060/681 Completed Open study to evaluate the efficacy and the safety of paroxetine in the treatment of depression associated with a physical disorders
29060/688 Completed A double-blind, placebo-controlled, 3-arm fixed dose study of paroxetine CR continuous treatment (12.5mg and 25mg) for Premenstrual Dysphoric Disorder. Study Listed on ClinicalStudyDataRequest.com
29060/689 Completed A Double-Blind, Placebo-Controlled, 3-Arm, Fixed-Dose Study of Paroxetine CR Continuous Treatment (12.5 mg/day and 25 mg/day) for Premenstrual Dysphoric Disorder Study Listed on ClinicalStudyDataRequest.com
29060/701 Completed A multi-center, double blind, placebo-controlled flexible dose study to evaluate the efficacy and safety of Paroxetine in children with major depression. Study Listed on ClinicalStudyDataRequest.com
29060/704 Completed A Randomized, Multi-center, 10-week, Double-blind, Placebo-Controlled, Flexible-Dose Study to Evaluate the Efficacy and Safety of Paroxetine in Children and Adolescents with Obsessive Compulsive Disorder Study Listed on ClinicalStudyDataRequest.com
29060/711 Completed A 3-Month, Double-blind, Placebo-controlled, Fixed-dose, Extension Study of Paroxetine CR (12.5 mg and 25 mg/day) Continuous Treatment for PMDD Patients Completing Studies 29060/677, 688 or 689 Study Listed on ClinicalStudyDataRequest.com
29060/715 Completed A Multi-center Study to Assess the Pharmacokinetics of Paroxetine Following Repeat-Dose Administration in Children and Adolescents with Obsessive Compulsive Disorder (OCD) and/or Depression Study Listed on ClinicalStudyDataRequest.com
29060/716 Completed A Multi-center, Open-label, Six-Month Extension Study to Assess the Long-term Safety of Paroxetine in Children and Adolescents with Major Depressive Disorder (MDD) or Obsessive Compulsive Disorder (OCD) Study Listed on ClinicalStudyDataRequest.com
29060/717 Completed A Double-Blind, Placebo-Controlled, 3-Arm, Fixed-Dose Study of Paroxetine CR Intermittent Dosing (12.5 mg and 25 mg) for Premenstrual Dysphoric Disorder Study Listed on ClinicalStudyDataRequest.com
29060/730 Completed Clinical comparison of paroxetine and placebo on the symptoms emerging during the taper phase of a chronic benzodiazepine treatment, in patients suffering from a variety of anxiety disorders
29060/785 Completed A double-blind, placebo-controlled, fixed-dosage study comparing the efficacy and tolerability of paroxetine CR and citalopram to placebo in the treatment of Major Depressive Disorder with anxiety Study Listed on ClinicalStudyDataRequest.com
29060/790 Completed A Double-blind, Placebo-controlled, Flexible-dose Study of Paroxetine CR in the Treatment of Patients with Social Anxiety Disorder Study Listed on ClinicalStudyDataRequest.com
29060/791 Completed A Randomized, Double-Blind, Placebo-Controlled, Flexible Dosage Trial to Evaluate the Efficacy and Tolerability of Paroxetine CR in Patients with Generalized Anxiety Disorder (GAD) Study Listed on ClinicalStudyDataRequest.com
29060/799 Completed BRL29060A in Posttraumatic Stress Disorder
29060/810 Completed A double-blind, placebo-controlled, 3-arm, fixed-dose study of 12.5 mg/day and 25mg/day Paroxetine CR in the treatment of Major Depression. Study Listed on ClinicalStudyDataRequest.com
29060/863 Completed A Post-Marketing Clinical Study of PAXIL Tablet in Patients with Depression or Depressive Episodes
29060/874 Completed A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Evaluating the Efficacy and Safety of Paroxetine CR in Elderly Outpatients Diagnosed with Major Depressive Disorder Study Listed on ClinicalStudyDataRequest.com
29060/877 Completed An open labeled, single sequence study to investigate the safety and pharmacokinetics of oral pimozide when co-administered with repeat dosing oral paroxetine 60 mg od in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
300 Completed A Multicenter Trial of Bupropion for Cocaine Dependence in Methadone-Maintained Patients – Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
30310/001 Completed An open, multicentred, non-comparative study to assess the efficacy, safety and tolerability of a single 400mg po dose of Oxibendazole in the treatment of intestinal helminth infections in adults
30310/002 Completed A multicentre, randomised, double-blind, parallel group study to assess the efficacy, safety and tolerability of a single 400mg po dose of Oxibendazole versus a single 500mg po dose of Mebendazole in the treatment of intestinal helminths in adults

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.